Personal CFO Solutions’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Sell |
3,313
-62
| -2% | -$25.1K | 0.25% | 77 |
|
|
2025
Q1 | $1.68M | Buy |
3,375
+51
| +2% | +$25.4K | 0.34% | 54 |
|
|
2024
Q4 | $1.73M | Sell |
3,324
-129
| -4% | -$67.1K | 0.34% | 54 |
|
|
2024
Q3 | $2.14M | Sell |
3,453
-100
| -3% | -$61.8K | 0.3% | 66 |
|
|
2024
Q2 | $1.97M | Buy |
3,553
+114
| +3% | +$63.1K | 0.3% | 63 |
|
|
2024
Q1 | $2M | Buy |
3,439
+1,329
| +63% | +$773K | 0.31% | 63 |
|
|
2023
Q4 | $1.12M | Buy |
2,110
+43
| +2% | +$22.8K | 0.19% | 99 |
|
|
2023
Q3 | $1.05M | Buy |
2,067
+20
| +1% | +$10.1K | 0.21% | 97 |
|
|
2023
Q2 | $1.07M | Buy |
2,047
+34
| +2% | +$17.7K | 0.22% | 92 |
|
|
2023
Q1 | $1.16M | Buy |
2,013
+77
| +4% | +$44.4K | 0.24% | 81 |
|
|
2022
Q4 | $1.07M | Buy |
1,936
+1,134
| +141% | +$625K | 0.23% | 82 |
|
|
2022
Q3 | $407K | Buy |
802
+6
| +0.8% | +$3.05K | 0.1% | 190 |
|
|
2022
Q2 | $433K | Buy |
796
+14
| +2% | +$7.62K | 0.1% | 182 |
|
|
2022
Q1 | $462K | Buy |
782
+77
| +11% | +$45.5K | 0.09% | 213 |
|
|
2021
Q4 | $470K | Buy |
705
+92
| +15% | +$61.3K | 0.09% | 208 |
|
|
2021
Q3 | $350K | Sell |
613
-33
| -5% | -$18.8K | 0.07% | 251 |
|
|
2021
Q2 | $326K | Buy |
646
+109
| +20% | +$55K | 0.07% | 267 |
|
|
2021
Q1 | $245K | Buy |
537
+12
| +2% | +$5.48K | 0.05% | 323 |
|
|
2020
Q4 | $245K | Buy |
525
+52
| +11% | +$24.3K | 0.06% | 300 |
|
|
2020
Q3 | $0 | Buy |
+473
| New | – | ﹤0.01% | 313 |
|